CCL5 and cancer: The results obtained in the experimental model used in this study, such as EMT enhancement in highly metastatic cell lines, and the expression of CCL5, which suggests an association with M2-TAMs in the tumor tissue, are generally consistent with previous reports on inflammation and tumor immunity, indicating that this model is very useful for cancer research, particularly within the TME.